The nuclear medicine group of Siemens Medical Systems in Hoffman Estates, IL, is giving a higher profile to its gamma camera remanufacturing capability. The company last month launched its Siemens Remanufactured Product (SRP) line, which it plans to
The nuclear medicine group of Siemens Medical Systems in Hoffman Estates, IL, is giving a higher profile to its gamma camera remanufacturing capability. The company last month launched its Siemens Remanufactured Product (SRP) line, which it plans to position as a viable alternative to new gamma cameras.
SRP cameras undergo a seven-step remanufacturing process, in which the systems are disassembled and rebuilt, with components repaired or replaced if necessary. The cameras are also refinished and include a one-year warranty, with a three-year warranty for crystals. Siemens claims that in some cases the systems emerge from the process better than when they were sold because they are brought up to current specifications, with state-of-the-art detectors, electronics, and other components.
In other Siemens nuclear medicine news, the company has released a new version of its ECAT ART positron emission tomography camera. Unveiled at the European Association of Nuclear Medicine meeting, the new ECAT ART features iterative reconstruction algorithms for better image quality and a single-photon scanning method that enables higher throughput for whole-body attenuation-corrected studies. Siemens first introduced ECAT ART at the 1994 Society of Nuclear Medicine meeting, and the camera carries a list price of $1.2 million (SCAN 6/15/94).
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.